Idursulfase and nausea Patient Reports February 12, 2012

Idursulfase Side Effects Report #5374125-0
Idursulfase side effect was reported by a Consumer or non-health professional from JAPAN on June 20, 2007. Male patient, 42 years of age, weighting 103.6 lb, was diagnosed with mucopolysaccharidosis ii and was treated with Idursulfase. After drug was administered, patient experienced the following side effects: depressed level of consciousness, headache , hypotension, nausea , pulse pressure decreased, yawning. Idursulfase dosage: (0.5 MG/KG, 1 IN 1 WK), INTRAVENOUS DRIP. During the same period patient was treated with VERAPAMIL, OMEPRAZOLE, ASPIRIN, DIGOXIN, TORSEMIDE, PIMOBENDAN, LEVOTHYROXINE, HYDROCORTISONE. Patient was hospitalized. Patient recovered.

Idursulfase Side Effects Report #5388697-3
Idursulfase side effect was reported by a Consumer or non-health professional from JAPAN on June 27, 2007. Male patient, 42 years of age, weighting 103.6 lb, was diagnosed with mucopolysaccharidosis ii and was treated with Idursulfase. After drug was administered, patient experienced the following side effects: blood immunoglobulin e increased, depressed level of consciousness, headache , hypotension, infusion related reaction, nausea , pulse pressure decreased, shock. Idursulfase dosage: (0.5 MG/KG, 1 IN 1WK), INTRAVENOUS DRIP. During the same period patient was treated with VERAPAMIL, OMEPRAZOLE, ASPIRIN, DIGOXIN, TORSEMIDE, PIMOBENDAN, LEVOTHYROXINE, HYDROCORTISONE. Patient was hospitalized. Patient recovered.

Idursulfase Side Effects Report #5331729-9
Idursulfase side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 05, 2007. Male patient, 15 years of age, weighting 98.33 lb, was diagnosed with mucopolysaccharidosis ii and was treated with Idursulfase. After drug was administered, patient experienced the following side effects: aspiration, chills, flushing, infusion related reaction, nausea , pneumonia , rash , rash erythematous, rash papular. Idursulfase dosage: (23 MG, 1 IN 1 WK), INTRAVENOUS DRIP. Patient was hospitalized. Patient recovered.